Human Anti-HIV-1 Env (clone A7) scFv-Fc Chimera

CAT#: VS-0125-FY6

The A7 scFv-Fc antibody plays a crucial role in neutralizing HIV-1, making it an important tool in the development of vaccines and therapies against HIV. Its unique structure allows it to effectively bind to the virus, neutralizing its infectivity and preventing the virus from entering host cells. Furthermore, ongoing research is focused on optimizing this antibody for enhanced potency and broader neutralization capabilities, which could significantly improve the outcomes of HIV treatment and vaccination strategies. Additionally, exploring its mechanism of action may reveal new insights into the immune response against HIV, ultimately aiding in the fight against this global epidemic.

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Species Reactivity
  • Human immunodeficiency virus (HIV)
  • Clone
  • A7
  • Applications
  • Neutralization
  • Related Disease
  • HIV infection

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Format
  • Liquid
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Stabilizer
  • No Stabilizers
  • Sterility
  • 0.2 μM filtered
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Applications

  • Application Notes
  • The A7 scFv-Fc antibodies have the potential to specifically target and bind to distinct epitopes on the HIV-1 envelope glycoprotein gp120. This targeting ability may play a crucial role in neutralizing HIV-1, making these antibodies a valuable asset in the development of vaccines and therapeutic strategies to combat HIV.

Target

  • Alternative Names
  • HIV-1 env glycoprotein; Human immunodeficiency virus-1 Glycoprotein
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0125-FY6. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Secondary Antibody

Isotype Control

See other products for "HIV-1 Env"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NABG-057 Recombinant Anti-HIV-1 env VHH Single Domain Antibody ELISA, IHC, FC, FuncS Llama VHH
CAT Product Name Application Type
MRO-2809CQ Human Anti-HIV-1 Env Recombinant Antibody (clone N03B11) ELISA Humanized IgM
CAT Product Name Application Type
VS-0125-FY69 Human Anti-HIV-1 Env (clone PGT121) scFv-Fc Chimera Neut Human IgG1, scFv-Fc
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare